Journal of Human Reproductive Science
Home Ahead of Print Current Issue Archives
   Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size    Users online: 1332

    Article Cited by others


Gonadotropin-releasing hormone agonist trigger is a better alternative than human chorionic gonadotropin in PCOS undergoing IVF cycles for an OHSS Free Clinic: A Randomized control trial

Krishna Deepika, Dhoble Snehal, Praneesh Gautham, Rathore Suvarna, Upadhaya Amit, Rao Kamini

Year : 2016| Volume: 9| Issue : 3 | Page no: 164-172

   This article has been cited by
1 Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF/ICSI cycles
Chengliang Zhou, Xinyue Yang, Yong Wang, Ji Xi, Hong Pan, Min Wang, Yuzhong Zhou, Yu Xiao
Human Reproduction. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Optimization of assisted reproductive technology outcomes in patients with polycystic ovarian syndrome: updates and unanswered questions
Victoria W. Fitz, Shruthi Mahalingaiah
Current Opinion in Endocrinology, Diabetes & Obesity. 2022; Publish Ah
[Pubmed]  [Google Scholar] [DOI]
3 Effect of GnRH agonist alone or combined with different low-dose hCG on cumulative live birth rate for high responders in GnRH antagonist cycles: a retrospective study
Yuxia He, Yan Tang, Shiping Chen, Jianqiao Liu, Haiying Liu
BMC Pregnancy and Childbirth. 2022; 22(1)
[Pubmed]  [Google Scholar] [DOI]
4 Recombinant human chorionic gonadotropin versus purified human chorionic gonadotropin trigger for In vitro Fertilization intracytoplasmic sperm injection cycle
Zeena Helmi, Zainab Mussaid
Mustansiriya Medical Journal. 2022; 21(2): 111
[Pubmed]  [Google Scholar] [DOI]
5 The freeze-all strategy after IVF: which indications?
Mathilde Bourdon, Chloé Maignien, Khaled Pocate-Cheriet, Geneviève Plu Bureau, Louis Marcellin, Catherine Patrat, Charles Chapron, Pietro Santulli
Reproductive BioMedicine Online. 2021; 42(3): 529
[Pubmed]  [Google Scholar] [DOI]
6 Gonadotropin-releasing hormone agonist (alone or combined with human chorionic gonadotropin) vs. human chorionic gonadotropin alone for ovulation triggering during controlled ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection:
Mathilde Bourdon, Maëliss Peigné, Céline Solignac, Bernadette Darné, Solène Languille, Khaled Pocate-Cheriet, Pietro Santulli
F&S Reviews. 2021; 2(4): 353
[Pubmed]  [Google Scholar] [DOI]
7 Genuine empty follicle syndrome: role of double trigger and delayed oocyte retrieval (DTDO)
AbdulMajiyd Noushin, Sankalp Singh, Aluvilayil Sonia, Swati Singh, Reema Basheer, Raiza Ashraf, AhmedN Waseem, Mohamed Ashraf
Journal of Human Reproductive Sciences. 2021; 14(1): 36
[Pubmed]  [Google Scholar] [DOI]
8 The use of GnRH-agonist trigger for the final maturation of oocytes in normal and low responders undergoing planned oocyte cryopreservation
Bat-Sheva L Maslow, Michael Guarnaccia, Cara Stefanacci, Leslie Ramirez, Joshua U Klein
Human Reproduction. 2020; 35(5): 1054
[Pubmed]  [Google Scholar] [DOI]


Read this article